aluates Reports

$ 0.0

Automative

Global Post Herpetic Neuralgia Drugs Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-36T10401

Global and United States Post Herpetic Neuralgia Drugs Market Report Forecast 2022 2028

BUY CHAPTERS

Global Post Herpetic Neuralgia Drugs Market Research Report 2025

Code: QYRE-Auto-36T10401

Report

September 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Depomed

Pfizer Inc

Daiichi Sankyo

Post Herpetic Neuralgia Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Post Herpetic Neuralgia Drugs Market

The global market for Post Herpetic Neuralgia Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Post Herpetic Neuralgia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post Herpetic Neuralgia Drugs.

The Post Herpetic Neuralgia Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Post Herpetic Neuralgia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Post Herpetic Neuralgia Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Post Herpetic Neuralgia Drugs Market Report

Report Metric	Details
Report Name	Post Herpetic Neuralgia Drugs Market
CAGR	5%
Segment by Type	Anticonvulsants Antidepressants Opioids Others
Segment by Application	Hospital Pharmacies Online Pharmacies Retail Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Depomed, Pfizer, Daiichi Sankyo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Post Herpetic Neuralgia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Post Herpetic Neuralgia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Post Herpetic Neuralgia Drugs Market report?

Ans: The main players in the Post Herpetic Neuralgia Drugs Market are Depomed, Pfizer, Daiichi Sankyo

What are the Application segmentation covered in the Post Herpetic Neuralgia Drugs Market report?

Ans: The Applications covered in the Post Herpetic Neuralgia Drugs Market report are Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Post Herpetic Neuralgia Drugs Market report?

Ans: The Types covered in the Post Herpetic Neuralgia Drugs Market report are Anticonvulsants, Antidepressants, Opioids, Others

1 Post Herpetic Neuralgia Drugs Market Overview

1.1 Product Definition

1.2 Post Herpetic Neuralgia Drugs by Type

1.2.1 Global Post Herpetic Neuralgia Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Anticonvulsants

1.2.3 Antidepressants

1.2.4 Opioids

1.2.5 Others

1.3 Post Herpetic Neuralgia Drugs by Application

1.3.1 Global Post Herpetic Neuralgia Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Retail Pharmacies

1.4 Global Post Herpetic Neuralgia Drugs Market Size Estimates and Forecasts

1.4.1 Global Post Herpetic Neuralgia Drugs Revenue 2020-2031

1.4.2 Global Post Herpetic Neuralgia Drugs Sales 2020-2031

1.4.3 Global Post Herpetic Neuralgia Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Post Herpetic Neuralgia Drugs Market Competition by Manufacturers

2.1 Global Post Herpetic Neuralgia Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Post Herpetic Neuralgia Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Post Herpetic Neuralgia Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Post Herpetic Neuralgia Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Post Herpetic Neuralgia Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Post Herpetic Neuralgia Drugs, Product Type & Application

2.7 Global Key Manufacturers of Post Herpetic Neuralgia Drugs, Date of Enter into This Industry

2.8 Global Post Herpetic Neuralgia Drugs Market Competitive Situation and Trends

2.8.1 Global Post Herpetic Neuralgia Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Post Herpetic Neuralgia Drugs Players Market Share by Revenue

2.8.3 Global Post Herpetic Neuralgia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Post Herpetic Neuralgia Drugs Market Scenario by Region

3.1 Global Post Herpetic Neuralgia Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Post Herpetic Neuralgia Drugs Sales by Region: 2020-2031

3.2.1 Global Post Herpetic Neuralgia Drugs Sales by Region: 2020-2025

3.2.2 Global Post Herpetic Neuralgia Drugs Sales by Region: 2026-2031

3.3 Global Post Herpetic Neuralgia Drugs Revenue by Region: 2020-2031

3.3.1 Global Post Herpetic Neuralgia Drugs Revenue by Region: 2020-2025

3.3.2 Global Post Herpetic Neuralgia Drugs Revenue by Region: 2026-2031

3.4 North America Post Herpetic Neuralgia Drugs Market Facts & Figures by Country

3.4.1 North America Post Herpetic Neuralgia Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Post Herpetic Neuralgia Drugs Sales by Country (2020-2031)

3.4.3 North America Post Herpetic Neuralgia Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Post Herpetic Neuralgia Drugs Market Facts & Figures by Country

3.5.1 Europe Post Herpetic Neuralgia Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Post Herpetic Neuralgia Drugs Sales by Country (2020-2031)

3.5.3 Europe Post Herpetic Neuralgia Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Post Herpetic Neuralgia Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Post Herpetic Neuralgia Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Post Herpetic Neuralgia Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Post Herpetic Neuralgia Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Post Herpetic Neuralgia Drugs Market Facts & Figures by Country

3.7.1 Latin America Post Herpetic Neuralgia Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Post Herpetic Neuralgia Drugs Sales by Country (2020-2031)

3.7.3 Latin America Post Herpetic Neuralgia Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Post Herpetic Neuralgia Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Post Herpetic Neuralgia Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Post Herpetic Neuralgia Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Post Herpetic Neuralgia Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Post Herpetic Neuralgia Drugs Sales by Type (2020-2031)

4.1.1 Global Post Herpetic Neuralgia Drugs Sales by Type (2020-2025)

4.1.2 Global Post Herpetic Neuralgia Drugs Sales by Type (2026-2031)

4.1.3 Global Post Herpetic Neuralgia Drugs Sales Market Share by Type (2020-2031)

4.2 Global Post Herpetic Neuralgia Drugs Revenue by Type (2020-2031)

4.2.1 Global Post Herpetic Neuralgia Drugs Revenue by Type (2020-2025)

4.2.2 Global Post Herpetic Neuralgia Drugs Revenue by Type (2026-2031)

4.2.3 Global Post Herpetic Neuralgia Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Post Herpetic Neuralgia Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Post Herpetic Neuralgia Drugs Sales by Application (2020-2031)

5.1.1 Global Post Herpetic Neuralgia Drugs Sales by Application (2020-2025)

5.1.2 Global Post Herpetic Neuralgia Drugs Sales by Application (2026-2031)

5.1.3 Global Post Herpetic Neuralgia Drugs Sales Market Share by Application (2020-2031)

5.2 Global Post Herpetic Neuralgia Drugs Revenue by Application (2020-2031)

5.2.1 Global Post Herpetic Neuralgia Drugs Revenue by Application (2020-2025)

5.2.2 Global Post Herpetic Neuralgia Drugs Revenue by Application (2026-2031)

5.2.3 Global Post Herpetic Neuralgia Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Post Herpetic Neuralgia Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Depomed

6.1.1 Depomed Company Information

6.1.2 Depomed Description and Business Overview

6.1.3 Depomed Post Herpetic Neuralgia Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Depomed Post Herpetic Neuralgia Drugs Product Portfolio

6.1.5 Depomed Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Post Herpetic Neuralgia Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Post Herpetic Neuralgia Drugs Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Daiichi Sankyo

6.3.1 Daiichi Sankyo Company Information

6.3.2 Daiichi Sankyo Description and Business Overview

6.3.3 Daiichi Sankyo Post Herpetic Neuralgia Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Daiichi Sankyo Post Herpetic Neuralgia Drugs Product Portfolio

6.3.5 Daiichi Sankyo Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Post Herpetic Neuralgia Drugs Industry Chain Analysis

7.2 Post Herpetic Neuralgia Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Post Herpetic Neuralgia Drugs Production Mode & Process Analysis

7.4 Post Herpetic Neuralgia Drugs Sales and Marketing

7.4.1 Post Herpetic Neuralgia Drugs Sales Channels

7.4.2 Post Herpetic Neuralgia Drugs Distributors

7.5 Post Herpetic Neuralgia Drugs Customer Analysis

8 Post Herpetic Neuralgia Drugs Market Dynamics

8.1 Post Herpetic Neuralgia Drugs Industry Trends

8.2 Post Herpetic Neuralgia Drugs Market Drivers

8.3 Post Herpetic Neuralgia Drugs Market Challenges

8.4 Post Herpetic Neuralgia Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Depomed

Pfizer Inc

Daiichi Sankyo

List of Tables

Table 1. Global Post Herpetic Neuralgia Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Post Herpetic Neuralgia Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Post Herpetic Neuralgia Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Post Herpetic Neuralgia Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Post Herpetic Neuralgia Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Post Herpetic Neuralgia Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Post Herpetic Neuralgia Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Post Herpetic Neuralgia Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Post Herpetic Neuralgia Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Post Herpetic Neuralgia Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Post Herpetic Neuralgia Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Post Herpetic Neuralgia Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Post Herpetic Neuralgia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post Herpetic Neuralgia Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Post Herpetic Neuralgia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Post Herpetic Neuralgia Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Post Herpetic Neuralgia Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Post Herpetic Neuralgia Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Post Herpetic Neuralgia Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Post Herpetic Neuralgia Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Post Herpetic Neuralgia Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Post Herpetic Neuralgia Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Post Herpetic Neuralgia Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Post Herpetic Neuralgia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Post Herpetic Neuralgia Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Post Herpetic Neuralgia Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Post Herpetic Neuralgia Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Post Herpetic Neuralgia Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Post Herpetic Neuralgia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Post Herpetic Neuralgia Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Post Herpetic Neuralgia Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Post Herpetic Neuralgia Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Post Herpetic Neuralgia Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Post Herpetic Neuralgia Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Post Herpetic Neuralgia Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Post Herpetic Neuralgia Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Post Herpetic Neuralgia Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Post Herpetic Neuralgia Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Post Herpetic Neuralgia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Post Herpetic Neuralgia Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Post Herpetic Neuralgia Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Post Herpetic Neuralgia Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Post Herpetic Neuralgia Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Post Herpetic Neuralgia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Post Herpetic Neuralgia Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Post Herpetic Neuralgia Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Post Herpetic Neuralgia Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Post Herpetic Neuralgia Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Post Herpetic Neuralgia Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Post Herpetic Neuralgia Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Post Herpetic Neuralgia Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Post Herpetic Neuralgia Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Post Herpetic Neuralgia Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Post Herpetic Neuralgia Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Post Herpetic Neuralgia Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Post Herpetic Neuralgia Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Post Herpetic Neuralgia Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Post Herpetic Neuralgia Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Post Herpetic Neuralgia Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Post Herpetic Neuralgia Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Post Herpetic Neuralgia Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Post Herpetic Neuralgia Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Post Herpetic Neuralgia Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Post Herpetic Neuralgia Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Post Herpetic Neuralgia Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Post Herpetic Neuralgia Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Post Herpetic Neuralgia Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Post Herpetic Neuralgia Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Depomed Company Information

Table 71. Depomed Description and Business Overview

Table 72. Depomed Post Herpetic Neuralgia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Depomed Post Herpetic Neuralgia Drugs Product

Table 74. Depomed Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Post Herpetic Neuralgia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Post Herpetic Neuralgia Drugs Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Daiichi Sankyo Company Information

Table 81. Daiichi Sankyo Description and Business Overview

Table 82. Daiichi Sankyo Post Herpetic Neuralgia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Daiichi Sankyo Post Herpetic Neuralgia Drugs Product

Table 84. Daiichi Sankyo Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Post Herpetic Neuralgia Drugs Distributors List

Table 88. Post Herpetic Neuralgia Drugs Customers List

Table 89. Post Herpetic Neuralgia Drugs Market Trends

Table 90. Post Herpetic Neuralgia Drugs Market Drivers

Table 91. Post Herpetic Neuralgia Drugs Market Challenges

Table 92. Post Herpetic Neuralgia Drugs Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Post Herpetic Neuralgia Drugs

Figure 2. Global Post Herpetic Neuralgia Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Post Herpetic Neuralgia Drugs Market Share by Type: 2024 & 2031

Figure 4. Anticonvulsants Product Picture

Figure 5. Antidepressants Product Picture

Figure 6. Opioids Product Picture

Figure 7. Others Product Picture

Figure 8. Global Post Herpetic Neuralgia Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Post Herpetic Neuralgia Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospital Pharmacies

Figure 11. Online Pharmacies

Figure 12. Retail Pharmacies

Figure 13. Global Post Herpetic Neuralgia Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Post Herpetic Neuralgia Drugs Market Size (2020-2031) & (US$ Million)

Figure 15. Global Post Herpetic Neuralgia Drugs Sales (2020-2031) & (K Units)

Figure 16. Global Post Herpetic Neuralgia Drugs Average Price (USD/Unit) & (2020-2031)

Figure 17. Post Herpetic Neuralgia Drugs Report Years Considered

Figure 18. Post Herpetic Neuralgia Drugs Sales Share by Manufacturers in 2024

Figure 19. Global Post Herpetic Neuralgia Drugs Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Post Herpetic Neuralgia Drugs Players: Market Share by Revenue in Post Herpetic Neuralgia Drugs in 2024

Figure 21. Post Herpetic Neuralgia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Post Herpetic Neuralgia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Post Herpetic Neuralgia Drugs Sales Market Share by Country (2020-2031)

Figure 24. North America Post Herpetic Neuralgia Drugs Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Post Herpetic Neuralgia Drugs Sales Market Share by Country (2020-2031)

Figure 28. Europe Post Herpetic Neuralgia Drugs Revenue Market Share by Country (2020-2031)

Figure 29. Germany Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Post Herpetic Neuralgia Drugs Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Post Herpetic Neuralgia Drugs Revenue Market Share by Region (2020-2031)

Figure 36. China Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Post Herpetic Neuralgia Drugs Sales Market Share by Country (2020-2031)

Figure 47. Latin America Post Herpetic Neuralgia Drugs Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Post Herpetic Neuralgia Drugs Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Post Herpetic Neuralgia Drugs Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Post Herpetic Neuralgia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Post Herpetic Neuralgia Drugs by Type (2020-2031)

Figure 57. Global Revenue Market Share of Post Herpetic Neuralgia Drugs by Type (2020-2031)

Figure 58. Global Post Herpetic Neuralgia Drugs Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Post Herpetic Neuralgia Drugs by Application (2020-2031)

Figure 60. Global Revenue Market Share of Post Herpetic Neuralgia Drugs by Application (2020-2031)

Figure 61. Global Post Herpetic Neuralgia Drugs Price (USD/Unit) by Application (2020-2031)

Figure 62. Post Herpetic Neuralgia Drugs Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Post Herpetic Neuralgia Therapies Market Research Report 2024

Global Post Herpetic Neuralgia Patches Market Research Report 2024

Global Herpes Zoste Drug Market Research Report 2025

Global Herpes Infection Treatment Market Research Report 2025

Global Neuropathic Pain Drugs Market Research Report 2024

Global Post operative Pain Therapeutics Market Research Report 2025

Global Trigeminal Neuralgia Treatment Medicine Market Insights Forecast to 2030

Global Trigeminal Neuralgia Therapeutics Market Research Report 2025

Global Genital Herpes Treatment Market Research Report 2024

Global Genital Herpes Treatment Drug Market Research Report 2025

Nerve Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Valacyclovir API Market Research Report 2025

Global Neuropathic Pain Therapeutics Market Research Report 2024

Herpes Simplex Virus Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acyclovir Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pain Relief Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Herpes Zoster Ophthalmicus Drug Market Insights Forecast to 2030

Global Poxviridae Infections Drug Market Research Report 2025

Global OTC Pain Medicines Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions